Alpha Tau Medical Ltd. (DRTSW)

IL — Healthcare Sector
Peers: DRTS  ICCC  OCS  LENZ  SNDX  REVBW 

Automate Your Wheel Strategy on DRTSW

With Tiblio's Option Bot, you can configure your own wheel strategy including DRTSW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol DRTSW
  • Rev/Share 0.0
  • Book/Share 0.7995
  • PB 3.8274
  • Debt/Equity 0.2183
  • CurrentRatio 5.8147
  • ROIC -0.5133

 

  • MktCap 259181082.0
  • FreeCF/Share 0.0
  • PFCF 0.0
  • PE -6.6414
  • Debt/Assets 0.1519
  • DivYield 0
  • ROE -0.4948

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 5
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

About Alpha Tau Medical Ltd. (DRTSW)

  • IPO Date
  • Website https://www.alphatau.com
  • Industry Biotechnology
  • CEO Uzi Sofer
  • Employees 125
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.